logo-loader

Full interview: BioCorRx continues to advance BICX102 naltrexone implant through regulatory approval process

Published: 09:16 05 Feb 2020 EST

BioCorRX (OTCQB: BICX) CEO Brady Granier joined Steve Darling from Proactive Vancouver on Skype to discuss the company getting their second tranche of a funding grant that was awarded by the National Institute on Drug Abuse. Granier talked about receiving this funding and what it will ve used for. 

Granier also told Proactive about their product BICX102 and wherein the pipeline it is.

Full interview: BioCorRx offers medical professionals free use of its...

BioCorRx Inc (OTCQB:BICX) CEO Brady Granier tells Proactive the California-based company will help support vulnerable patients recover from alcohol or drug dependencies through the coronavirus pandemic. Granier says the addiction treatment solutions company is offering free access to its...

on 04/07/2020